Assuming show is required, the following results were found.

  • Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS

    biomarker for predicting multiple sclerosis (MS) disability progression; new longer-term Ocrevus data of more than six years show reduction of disability progression in relapsing and primary progressive MSBreadth of data reinforce Genentech's commitment...

    https://mschristian.org/index.php/blog/genentech-to-present-pivotal-data-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-and-six-year-ocrevus-ocrelizumab-data-in-multiple-sclerosis-at-ectrims
  • Diagnosis and Symptoms of Secondary Progressive MS

    for SPMS No single test can confirm that you have SPMS. But your doctor can track the changes in your disease withtests that show how much nerve damage you have. MRI (magnetic resonance imaging). In MS, the immune system -- your body's defense against...

    https://mschristian.org/index.php/blog/diagnosis-and-symptoms-of-secondary-progressive-ms
  • New treatment shows promise to reverse celiac disease

    M.Psych. (Editor)Oct 22 2019 Results of a new phase 2 clinical trial using technology developed at Northwestern Medicine show it is possible to induce immune tolerance to gluten in individuals with celiac disease. The findings may pave the way for...

    https://mschristian.org/index.php/blog/new-treatment-shows-promise-to-reverse-celiac-disease
  • Does sunlight change our gut microbiome?

    Scientists show that ultraviolet (UV) light exposure leads to changes in the gut microbiome, but only in volunteers who were deficient in vitamin D. Share on PinterestCan sunlight affect our gut microbiomes? There is plenty of evidence that links...

    https://mschristian.org/index.php/blog/does-sunlight-change-our-gut-microbiome
  • About MRIs and Other Scans - How Does Radiology Help Diagnose MS?

    Using contrast dye to detect active inflammation, this scan highlights new lesions or lesions that are growing. It can also show dark areas that indicate possible permanent damage.T2-weighted brain MRI. This scan detects all old and new lesions and...

    https://mschristian.org/index.php/blog/about-mris-and-other-scans-how-does-radiology-help-diagnose-ms
  • Mechanism controlling multiple sclerosis risk identified

    further discovered a so-called epigenetic regulation of HLA expression as the mechanism mediating this effect. "We show for the first time that epigenetic mechanisms can cause the disease.In addition, we can connect this mechanism to the genetic variant...

    https://mschristian.org/index.php/blog/mechanism-controlling-multiple-sclerosis-risk-identified
  • #ECTRIMS2019 - Are Injectables Inappropriate for Active Relapsing MS? - Multiple Sclerosis News Today

    treatments in Europe, which included 16,808 patients, approximately half of whom had relapsing-remitting MS (RRMS). Results showed that costs and utility (meaning the patient’s quality of life) were highly correlated with disease severity and...

    https://mschristian.org/index.php/blog/ectrims2019-are-injectables-inappropriate-for-active-relapsing-ms-multiple-sclerosis-news-today
  • Can Anti-TNF Drugs Reduce Alzheimer's Risk?

    that risk was reduced in patients who used anti-TNF biologics, an analysis of 56 million adults' electronic health records showed. While rheumatoid arthritis increased Alzheimer's risk, it was reduced in patients taking etanercept (Enbrel), adalimumab...

    https://mschristian.org/index.php/blog/can-anti-tnf-drugs-reduce-alzheimer-s-risk
  • Arthritis group offers first guidelines for patients who use CBD for joint pain

    Sept 24, 2019 As seen on NBC's Today show By Erika Edwards CBD has exploded in popularity over the last year, with countless numbers of people trying it as a sleep aid or relief for pain and anxiety. One concern is, there's been no guidance on how to...

    https://mschristian.org/index.php/blog/arthritis-group-offers-first-guidelines-for-patients-who-use-cbd-for-joint-pain
  • 5 Ways to Have a Better MRI Experience With MS

    areas where the myelin that normally protects nerve fibers has been damaged, that are typical of MS. Over time, repeat MRIs show your doctor whether you have developed additional lesions and whether existing lesions have enlarged or otherwise changed....

    https://mschristian.org/index.php/blog/5-ways-to-have-a-better-mri-experience-with-ms
  • L-Selectin as a Biomarker for Progressive Multifocal Leukoencephalopathy Risk With Natalizumab Treatment - Neurology Advisor

    including 15 patients with PML, that were prospectively collected between January 2014 and November 2018. The data show that natalizumab treatment was associated with lowered CD62L levels (effect size=−12.51; P =9.5×10-13), and cessation of natalizumab...

    https://mschristian.org/index.php/blog/l-selectin-as-a-biomarker-for-progressive-multifocal-leukoencephalopathy-risk-with-natalizumab-treatment-neurology-advisor
  • B cells among factors leading to brain lesions in multiple sclerosis

    Date:Source:University of ZurichSummary:A team of researchers has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain. B cells, a different type of immune cell, also play a role. These...

    https://mschristian.org/index.php/blog/b-cells-among-factors-leading-to-brain-lesions-in-multiple-sclerosis
  • Link between gut flora and multiple sclerosis discovered

    antigen," says Mireia Sospedra. For the genetically defined subgroup of MS patients examined by the researchers, results show that gut microbiota could play a far greater role in the pathogenesis of the disease than previously assumed. Mireia Sospedra...

    https://mschristian.org/index.php/blog/link-between-gut-flora-and-multiple-sclerosis-discovered
  • New clues to the origin and progression of multiple sclerosis

    group of cells, known as oligodendrocytes, in the central nervous system of a mouse model of multiple sclerosis (MS), shows that they might have a significant role in the development of the disease. The discovery can lead to new therapies targeted at...

    https://mschristian.org/index.php/blog/new-clues-to-the-origin-and-progression-of-multiple-sclerosis
  • Cannabis-based drug in combination with other anti-spasticity

    with motor neuron disease, according to a phase 2 trial of 60 adults published in The Lancet Neurology journal. The findings show for the first time that adults with motor neuron disease taking first-line anti-spasticity drugs who were then treated with...

    https://mschristian.org/index.php/blog/cannabis-based-drug-in-combination-with-other-anti-spasticity
  • Multiple sclerosis: Helping cells to help themselves

    which restore the electrical insulation around damaged nerve cells." Using a mouse model, the research team were able to show that a reduction in Chi3l3 levels in the brain significantly impairs the body's capacity for oligodendrocyte production, while...

    https://mschristian.org/index.php/blog/multiple-sclerosis-helping-cells-to-help-themselves
  • Genentech’s Satralizumab Significantly Reduced Relapse Risk in Second Positive Phase III Study for Neuromyelitis Optica Spectrum Disorder

    Pivotal Phase III SAkuraStar study shows 55% reduction in the risk of relapse for satralizumab monotherapy versus placebo presented at ECTRIMS Congress 2019 74% reduction in the risk of relapse for satralizumab monotherapy versus placebo in people with...

    https://mschristian.org/index.php/blog/genentech-s-satralizumab-significantly-reduced-relapse-risk-in-second-positive-phase-iii-study-for-neuromyelitis-optica-spectrum-disorder
  • Genentech Presents New Six-Year Ocrevus (Ocrelizumab) Data Which Showed That Earlier Initiation and Continuation of Treatment Reduced Disability Progression in Multiple Sclerosis

    SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- – Post-hoc analysis from a Phase III open-label extension study showed a 42% reduction in the risk of PPMS patients needing a wheelchair after six and a half years of Ocrevus treatment compared with...

    https://mschristian.org/index.php/blog/genentech-presents-new-six-year-ocrevus-ocrelizumab-data-which-showed-that-earlier-initiation-and-continuation-of-treatment-reduced-disability-progression-in-multiple-sclerosis
  • Trump’s proposed vapor ban leaves industry in state of turmoil, confusion

    flavored e-liquid via market authorization requirements based on preliminary results from the National Youth Tobacco Survey showing continued utilization of flavored e-products by youth. Trump’s first public comments on vaping come as health authorities...

    https://mschristian.org/index.php/blog/trump-s-proposed-vapor-ban-leaves-industry-in-state-of-turmoil-confusion
  • Multiple sclerosis: Perilous ruptures

    with an animal model of MS has identified a putative mechanism that can result in the degeneration of axons. They have shown that minuscule ruptures in the cell membrane allow calcium ions to percolate into the neuron, disrupting the ionic balance and...

    https://mschristian.org/index.php/blog/multiple-sclerosis-perilous-ruptures

Results 1 - 20 of 45
 
 

Follow Us on Twitter

Follow Us On Twitter - Image